The main finding of this study is that individuals with NAFLD have increased plasma DPP4 activity than no-NAFLD subjects, regardless of the presence of obesity and metabolic disease. The gene discussed is DPP4; the disease is metabolic dysfunction-associated steatotic liver disease.